As of 2026-09-23, the EV/EBITDA ratio of Revolution Medicines Inc (RVMD) is -64.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RVMD's latest enterprise value is 41,222.58 mil USD. RVMD's TTM EBITDA according to its financial statements is -639.94 mil USD. Dividing these 2 quantities gives us the above RVMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2026-09-22 | -64.42 |
| 2026-09-21 | -64.38 |
| 2026-09-18 | -63.78 |
| 2026-09-17 | -65.77 |
| 2026-09-16 | -65.43 |
| 2026-09-15 | -68.40 |
| 2026-09-14 | -68.49 |
| 2026-09-11 | -68.04 |
| 2026-09-10 | -67.90 |
| 2026-09-09 | -69.34 |
| 2026-09-08 | -69.22 |
| 2026-09-04 | -70.12 |
| 2026-09-03 | -70.40 |
| 2026-09-02 | -69.85 |
| 2026-09-01 | -70.07 |
| 2026-08-31 | -68.64 |
| 2026-08-28 | -69.41 |
| 2026-08-27 | -73.81 |
| 2026-08-26 | -71.92 |
| 2026-08-25 | -70.57 |
| 2026-08-24 | -70.64 |
| 2026-08-21 | -69.93 |
| 2026-08-20 | -70.69 |
| 2026-08-19 | -71.66 |
| 2026-08-18 | -72.10 |
| 2026-08-17 | -70.77 |
| 2026-08-14 | -68.02 |
| 2026-08-13 | -67.45 |
| 2026-08-12 | -68.54 |
| 2026-08-11 | -68.63 |
| 2026-08-10 | -69.10 |
| 2026-08-07 | -68.50 |
| 2026-08-06 | -66.06 |
| 2026-08-05 | -65.89 |
| 2026-08-04 | -64.62 |
| 2026-08-03 | -60.96 |
| 2026-07-31 | -62.65 |
| 2026-07-30 | -64.19 |
| 2026-07-29 | -60.45 |
| 2026-07-28 | -61.43 |
| 2026-07-27 | -62.82 |
| 2026-07-24 | -63.21 |
| 2026-07-23 | -63.05 |
| 2026-07-22 | -61.15 |
| 2026-07-21 | -61.24 |
| 2026-07-20 | -60.27 |
| 2026-07-17 | -62.19 |
| 2026-07-16 | -59.87 |
| 2026-07-15 | -61.62 |
| 2026-07-14 | -61.79 |